Professional Media briefs

Dove Medical Press is launching a series of video abstracts of papers from their 100-plus open-access, peer-reviewed medical and scientific journals. The abstracts, each presented by the paper's author, are from one to four minutes long, giving an overview of the content and motivation behind the published work. 

Monthly Prescribing Reference (MPR) has released the MPR Mobile App for Apple iOS and Android platforms. It offers HCPs a free Drug Interactions Checker with a database of nearly 7,000 agents—and interaction data. MPR is published by Prescribing Reference, Inc., a division of Haymarket Media, which publishes MM&M

Unbound Medicine, a provider of knowledge management solutions for healthcare, is now in a licensing relationship with medical publisher Elsevier. The Harriet Lane Handbook for Apple iOS, Android and BlackBerry is the first mobile digital product to be offered through this partnership.

Apple has a new section in its iTunes store for apps that cater to HCPs. The physician-friendly division has apps in six categories: reference, educational, EMR & patient monitoring, imaging, point-of-care and personal care (for consumers).

You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.